The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Anavex Life Sciences Corp. - Update on Phase 2 Clinical Trial for Alzheimer's Indication

SNNLive spoke with Christopher U. Missling, PhD, President & CEO of Anavex Life Sciences Corp. (OTCQX: AVXL) at the SeeThruEquity MicroCap Investor Conference 2014 in New York City, NY.

Share With

Monday, December 15, 2014

   

© 2017 Stock News Now